Update on transplanting beta cells for reversing type 1 diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 3, 2010, Pages 655-667

  Robertson, R Paul ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Beta cells; Islet transplantation; Pancreas transplantation; Type 1 diabetes

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; GLUCOCORTICOID; HEMOGLOBIN A1C; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ABDOMINAL BLEEDING; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FISTULA; GENE EXPRESSION; GRAFT PANCREATITIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SYNTHESIS; ORGAN DONOR; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOCYST; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SURGICAL INFECTION; SURVIVAL RATE; THROMBOSIS;

EID: 77955763034     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.05.010     Document Type: Review

References (46)

1. Kelly W.D., Lillehei R.C., Merkel F.K., et al. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967, 61:827-837.
2. Gruessner A.C., Sutherland D.E. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002. Clin Transpl 2002, 41-77.
3. Najarian J.S., Sutherland D.E., Baumgartner D., et al. Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg 1980, 192:526-542.
4. Wahoff D.C., Papalois B.E., Najarian J.S., et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 1995, 222:562-575. [discussion: 575-69].
5. Shapiro A.M., Lakey J.R., Ryan E.A., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
6. Diem P., Abid M., Redmon J.B., et al. Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 1990, 39:534-540.
7. La Rocca E., Secchi A., Parlavecchia M., et al. Lipid metabolism after successful kidney and pancreatic transplantation. Transplant Proc 1991, 23:1672-1673.
8. Larsen J.L., Stratta R.J., Ozaki C.F., et al. Lipid status after pancreas-kidney transplantation. Diabetes Care 1992, 15:35-42.
9. Katz H.H., Nguyen T.T., Velosa J.A., et al. Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipients. Mayo Clin Proc 1994, 69:231-236.
10. Ryan E.A., Lakey J.R., Paty B.W., et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002, 51:2148-2157.
11. Ryan E.A., Paty B.W., Senior P.A., et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005, 54:2060-2069.
12. Shapiro A.M., Ricordi C., Hering B.J., et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006, 355:1318-1330.
13. Froud T., Ricordi C., Baidal D.A., et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005, 5:2037-2046.
14. Toso C., Baertschiger R., Morel P., et al. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. Am J Transplant 2006, 6:1049-1058.
15. O'Connell P.J., Hawthorne W.J., Holmes-Walker D.J., et al. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial. Med J Aust 2006, 184:221-225.
16. Cure P., Pileggi A., Froud T., et al. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation 2008, 85:801-812.
17. Deng S., Markmann J.F., Rickels M., et al. Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival. Transplantation 2009, 88:820-825.
18. 2007 Update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR). Cell Transplant 2009, 18:753-767. CITR Research Group.
19. Robertson R.P. Long-term pancreas transplantation: consequences on beta cell function and reserve. Diabetes 2004, 53:633-645.
20. Banarer S., McGregor V.P., Cryer P.E. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002, 51:958-965.
21. Zhou H., Tran P.O., Yang S., et al. Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the " switch-off" hypothesis. Diabetes 2004, 53:1482-1487.
22. Kendall D.M., Rooney D.P., Smets Y.F., et al. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 1997, 46:249-257.
23. Paty B., Ryan E., Shapiro A.M., et al. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 2002, 51(12):3428-3434.
24. Rickels M.R., Schutta M.H., Mueller R., et al. Islet cell hormonal responses to hypoglycemia after human islet trasnplatation for type 1 diabetes. Diabetes 2006, 54:3206-3211.
25. Zhou H., Zhang T., Bogdani M., et al. Intrahepatic glucose flux as a mechanism for defective intrahepatic islet alpha-cell response to hypoglycemia. Diabetes 2008, 57:1567-1574.
26. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-985. DCCT Research Group.
27. Ramsay R.C., Goetz F.C., Sutherland D.E., et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 1988, 318:208-214.
28. Petersen M.R., Vine A.K. University of Michigan Pancreas Transplant Evaluation Committee: progression of diabetic retinopathy after pancreas transplantation. Ophthalmology 1990, 97:496-502.
29. Scheider A., Meyer-Schwickerath E., Nusser J., et al. Diabetic retinopathy and pancreas transplantation: a 3-year follow-up. Diabetologia 1991, 34(Suppl 1):S95-S99.
30. Koznarova R., Saudek F., Sosna T., et al. Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000, 9:903-908.
31. Fioretto P., Steffes M.W., Sutherland D.E., et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998, 339:69-75.
32. Navarro X., Kennedy W.R., Loewenson R.B., et al. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990, 39:802-806.
33. Aridge D., Reese J., Niehoff M., et al. Effect of successful renal and segmental pancreatic transplantation on peripheral and autonomic neuropathy. Transplant Proc 1991, 23:1670-1671.
34. Gaber A.O., Cardoso S., Pearson S., et al. Improvement in autonomic function following combined pancreas-kidney transplantation. Transplant Proc 1991, 23:1660-1662.
35. Allen R.D., Al-Harbi I.S., Morris J.G., et al. Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 1997, 63:830-838.
36. Jukema J.W., Smets Y.F., van der Pijl J.W., et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002, 25:906-911.
37. Zehrer C.L., Gross C.R. Comparison of quality of life between pancreas/kidney and kidney transplant recipients: 1-year follow-up. Transplant Proc 1994, 26:508-509.
38. Piehlmeier W., Bullinger M., Nusser J., et al. Quality of life in type 1 (insulin-dependent) diabetic patients prior to and after pancreas and kidney transplantation in relation to organ function. Diabetologia 1991, 34(Suppl 1):S150-S157.
39. Barrou B., Baldi A., Bitker M.O., et al. Pregnancy after pancreas transplantation: report of four new cases and review of the literature. Transplant Proc 1995, 27:3042-3044.
40. Fiorina P., Folli F., Bertuzzi F., et al. Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 2003, 26:1129-1136.
41. Toso C., Shapiro A.M., Bowker S., et al. Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome. Transplantation 2007, 84:664-666.
42. Sibley R.K., Sutherland D.E., Goetz F., et al. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985, 53:132-144.
43. Robertson R.P. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004, 350:694-705.
44. Kemp C.B., Knight M.J., Scharp D.W., et al. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia 1973, 9:486-491.
45. Merani S., Toso C., Emamaullee J., et al. Optimal implantation site for pancreatic islet transplantation. Br J Surg 2008, 95:1449-1461.
46. Robertson R.P., Lanz K.J., Sutherland D.E., et al. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002, 73:736-741.